News
We recently published 10 Resilient Stocks Defying Market Sentiment. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of ...
Zacks.com on MSN2d
Can Recent Pipeline Expansion Efforts Offset RXRX's Earlier Losses?Recursion Pharmaceuticals bets on REC-4881, cancer candidates and new hypophosphatasia therapy to rebuild momentum after key drug cuts rattled investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback